Initiative Cuts Overuse of Tests, Treatments for Bronchiolitis

Share this content:
Initiative Cuts Overuse of Tests, Treatments for Bronchiolitis
Initiative Cuts Overuse of Tests, Treatments for Bronchiolitis

FRIDAY, May 11, 2018 (HealthDay News) -- A multidisciplinary improvement initiative can reduce overuse of interventions for bronchiolitis, according to a study published online May 11 in Pediatrics.

In an effort to reduce overuse of interventions for children with a clinical diagnosis of bronchiolitis, Amy Tyler, M.D., from the Children's Hospital Colorado in Aurora, and colleagues used a multidisciplinary event to initiate examination of the problem and develop interventions for patients admitted to a non-intensive care unit setting with a primary or secondary diagnosis of bronchiolitis. The interventions included sharing provider-specific data and asking providers to pledge to reduce use. Data were collected and analyzed using a real-time data dashboard.

The researchers found that during the intervention season there was improvement for all outcomes for inpatients. Comparing baseline to intervention values for all admitted patients and patients who were discharged from the emergency department or urgent care, there was a significant decrease in the ordering of chest radiographs (from 22.7 to 13.6 percent), respiratory viral testing (from 12.5 to 9.8 percent), and bronchodilators (from 17.5 to 10.3 percent), with no changes in balancing measures for bronchiolitis.

"This multidisciplinary improvement initiative resulted in a significant reduction in use for bronchiolitis care at our institution," the authors write. "Our approach, which included a novel, real-time data dashboard and interventions such as individual providers pledging to reduce use, may have the potential to reduce overuse in other settings and diseases."

Abstract/Full Text (subscription or payment may be required)

Share this content:

is free, fast, and customized just for you!




Already a member?

Sign In Now »

Trending Activities

All Professions

Drug Lookup

Browse drugs by: BrandGenericDisease

More in Home

FDA Permits Marketing of Brain Stimulation Device for OCD

FDA Permits Marketing of Brain Stimulation Device for ...

FDA previously approved transcranial magnetic stimulation for major depression, certain migraines

Comments Open on End of NIH Review for Gene Therapy Studies

Comments Open on End of NIH Review for ...

NIH oversight panel no longer plans to review all applications for gene therapy experiments

U.S. Measles Outbreak Hits 107 Cases in 21 States, D.C.

U.S. Measles Outbreak Hits 107 Cases in 21 ...

Outbreak on track to exceed last year's; most of the people who got measles weren't vaccinated

is free, fast, and customized just for you!




Already a member?

Sign In Now »